China Bond Market Meltdown Brings World of Hidden Bills to Light
0 comments
InvestorPlace
The Novavax Rebound Is Just Warming Up
As recently as late October, it seemed like Novavax (NASDAQ:NVAX) was becoming an “also ran” in the vaccine horse race. For weeks, investors were bailing out of NVAX stock on news of Merck’s (NYSE:MRK) antiviral Covid-19 pill plus reports of NVAX facing production headwinds. Source: Ascannio/Shutterstock.com But now, as positive news is starting to come out? It may have been premature to say NVAX stock was falling out of the running. Obtaining emergency use authorization (EUA) in Indonesia may s